Valbiotis S.A.
ALVAL.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €24,007 | €62,310 | €36,413 | €62,731 |
| - Cash | €11,580 | €25,017 | €20,828 | €21,819 |
| + Debt | €5,719 | €6,880 | €7,177 | €7,592 |
| Enterprise Value | €18,146 | €44,173 | €22,762 | €48,504 |
| Revenue | €175 | €4,733 | €785 | €298 |
| % Growth | -96.3% | 502.9% | 163.4% | – |
| Gross Profit | -€2,443 | €2,689 | €767 | €282 |
| % Margin | -1,396% | 56.8% | 97.7% | 94.6% |
| EBITDA | -€9,172 | -€6,411 | -€11,134 | -€9,142 |
| % Margin | -5,241.1% | -135.5% | -1,418.3% | -3,067.8% |
| Net Income | -€10,025 | -€7,368 | -€12,312 | -€8,681 |
| % Margin | -5,728.6% | -155.7% | -1,568.4% | -2,913.1% |
| EPS Diluted | -0.63 | -0.59 | -1.22 | -0.95 |
| % Growth | -6.8% | 51.6% | -28.4% | – |
| Operating Cash Flow | -€11,537 | -€8,056 | -€9,192 | -€7,156 |
| Capital Expenditures | -€261 | -€263 | -€288 | -€421 |
| Free Cash Flow | -€11,798 | -€8,303 | -€9,480 | -€7,577 |